Updated: AstraZeneca says there’s ‘very limited’ impact on Farxiga after US drug pricing negotiations

As­traZeneca has con­clud­ed its price ne­go­ti­a­tions with the IRA for its block­buster drug Farx­i­ga, in the lat­est up­date for phar­ma com­pa­nies un­der­go­ing the process. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.